Respiratory infections can be caused by a range of viral and bacterial pathogens that may present with similar symptoms, making rapid differential testing valuable in supporting clinical assessment. The Biopanda COVID-19, Influenza A+B, RSV, Adenovirus & M. pneumoniae Antigen Combo Rapid Test provides a convenient multiplex solution for the simultaneous detection of multiple respiratory pathogens from a single nasopharyngeal swab sample. The test detects SARS-CoV-2, Influenza A+B, Respiratory Syncytial Virus (RSV), Adenovirus and Mycoplasma pneumoniae antigens, providing healthcare professionals and clinical laboratories with clear visual results in just 15 minutes without the need for a specialist analyser.
Catalogue Number: RAPG-RSPV-005
Kit Size: 10 Tests
Assay Time: 15 minutes
Storage: 2-30°C
Specimen: Nasopharyngeal Swab
Results: Read visually
Description:
The Biopanda COVID-19 / Influenza A+B / RSV / Adenovirus / M.pneumoniae Antigen Combo lateral flow immuno-chromatographic assay is a qualitative test for the detection of SARS-CoV-2 Nucleocapsid protein, Influenza A+B, Respiratory Syncytial Virus (RSV), Adenovirus, and M.pneumoniae antigens present in nasopharyngeal swab samples.
It is intended for use as a tool to assist in the diagnosis of SARS-CoV-2, Influenza A+B, RSV, Adenovirus, and M.pneumoniae, in conjunction with other tests.
Respiratory infections can be caused by a variety of viral and bacterial pathogens and may produce similar clinical symptoms, including cough, fever, sore throat, congestion and general respiratory discomfort. As symptoms alone may not clearly indicate the causative pathogen, testing can help support differential diagnosis and appropriate patient management.
Multiplex respiratory testing provides a convenient approach to screening for several respiratory pathogens simultaneously from a single patient specimen. This can be particularly valuable when investigating respiratory illness where multiple potential causes need to be considered.
SARS-CoV-2, Influenza A+B, Respiratory Syncytial Virus (RSV), Adenovirus and Mycoplasma pneumoniae are important causes of respiratory infection. Testing for these pathogens within a single assay provides a broader screening approach than testing for one respiratory pathogen alone.
The Biopanda COVID-19, Influenza A+B, RSV, Adenovirus & M. pneumoniae Antigen Combo Rapid Test qualitatively detects these respiratory pathogen antigens from a single nasopharyngeal swab sample, with visually read results in just 15 minutes. The test provides a practical multiplex screening solution to assist healthcare and laboratory professionals in the differential diagnosis of respiratory infections alongside clinical assessment and other appropriate diagnostic procedures.
How to order:
Via the contact us page, fill in the form with all the necessary details and we will email you back ASAP.
Or, email us directly for general queries (please include the product catalogue number in the subject line, if applicable).